爱朋医疗：有持股5%以上股东拟减持

Core Viewpoint - The major shareholder of Aipeng Medical, Beijing Zhanghong Private Fund Management Co., Ltd., plans to reduce its holdings in the company due to funding needs, with a total reduction of up to 252,090 shares, which is approximately 2.1% of the total share capital [1][2]. Group 1: Shareholder Reduction Plan - The shareholder, Zhanghong Selected No. 1 Private Securities Investment Fund, holds 5.6% of the company's total shares and intends to reduce its holdings by up to 126,050 shares through centralized bidding and another 126,050 shares through block trading [2]. - The reduction is based on market prices and is expected to take place within three months after the announcement [2]. Group 2: Financial Performance - In the first three quarters of the year, Aipeng Medical reported a revenue of 252 million yuan, a year-on-year decrease of 8.41%, and a net profit attributable to shareholders of -11.48 million yuan, a decline of 401.64% [3]. - The third quarter showed a net profit of 7.89 million yuan, reflecting a year-on-year increase of 255.22% [3]. Group 3: Company Background - Aipeng Medical focuses on pain management and upper respiratory tract management, while also expanding into intelligent medical device ecosystems and innovative businesses such as brain-machine interfaces and rapid rehabilitation [3]. - The company has a stake in Changzhou Ruishen'an Medical Device Co., Ltd., which specializes in the research, production, and sales of medical devices related to brain nerve regulation [3].